All posts tagged "Biotech and Pharmaceuticals"
-
Analysis
Eli Lilly posts blended quarter whilst call for for weight reduction, diabetes medicine soars
6 February 2025The Lilly Biotechnology Middle in San Diego, California, on March 1, 2023. Mike Blake | Reuters...
-
Analysis
Novo Nordisk CEO says he’s assured about Wegovy provide, next-generation weight reduction medicine
5 February 2025It’s been a rocky few months for Novo Nordisk. Prescription knowledge from IQVIA suggests Novo’s weight...
-
Analysis
Novo Nordisk posts web benefit beat as Wegovy gross sales bounce 107% in fourth quarter
5 February 2025Scientific bottles and syringe are distinguishable with Novo Nordisk brand displayed on a display screen within...
-
Analysis
Pfizer tops profits estimates as Covid gross sales beat expectancies and value cuts repay
4 February 2025Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Boulevard Magazine’s Month of The...
-
Analysis
Merck’s 2025 income outlook falls scale down because it pauses Gardasil vaccine shipments to China
4 February 2025Sopa Photographs | Lightrocket | Getty Photographs Merck on Tuesday issued full-year 2025 income steering that...
-
Analysis
Swiss pharma gigantic Novartis posts better-than-expected fourth-quarter gross sales
31 January 2025An place of work development designed through Frank O. Gehry on the Novartis AG headquarters campus...
-
Analysis
We’re slicing our value goal on Danaher as frustration mounts upcoming a messy quarter
29 January 2025Danaher stocks are beneath force Wednesday because the Membership retaining’s fourth-quarter income effects got here in...
-
Analysis
J&J beats quarterly gross sales and benefit estimates on most cancers drug gross sales
22 January 2025The Johnson & Johnson emblem is displayed at corporate places of work on October 17, 2023...
-
Analysis
Walgreens effects lead estimates as drugstore chain works to slash prices
10 January 2025Crowd advance via a Walgreens on Nov. 3, 2024 in Brookline, Massachusetts. Danielle DeVries | CNBC...
-
Analysis
Pfizer forecasts 2025 benefit in series with expectancies because it seeks turnaround
17 December 2024Pfizer CEO Albert Bourla speaks right through a press convention nearest a consult with to supervise...
Trending
